Nephrol Dial Transplant (2001) 16: 1120-1129
© 2001 European Renal Association-European Dialysis and Transplant Association
Registry Report
Renal replacement therapy in Europe: the results of a collaborative effort by the ERAEDTA registry and six national or regional registries
1 ERAEDTA Registry, Department of Medical Informatics, Academic Medical Center, University of Amsterdam, Amsterdam; 2 Dutch End-Stage Renal Disease Registry (RENINE), Erasmus University Hospital, Rotterdam, The Netherlands; 3 FrenchBelgian Nephrologists Registry, Centre Hospitalier Etterbeek-Ixelles, Brussels, Belgium; 4 Leiden University Medical Centre, Department of Clinical Epidemiology, Leiden, The Netherlands; 5 Finnish Kidney Disease Registry and Department of Medicine, Helsinki University Hospital, Helsinki, Finland; 6 Austrian Dialysis and Transplant Registry (OEDTR), General Hospital of Wels, Wels, Austria; 7 Norwegian Renal Registry, Institute of Immunology, Rikshospitalet University Hospital, Oslo, Norway; 8 Scottish Renal Registry, Glasgow Royal Infirmary, Glasgow, UK
Abstract
Background. In June 2000 a new ERAEDTA Registry Office was opened in Amsterdam. This Registry will only collect core data on renal replacement therapy (RRT) through national and regional registries. This paper reports the technical and epidemiological results of a pilot study combining the data from six registries.
Methods. Data from the national renal registries of Austria, Finland, French-Belgium, The Netherlands, Norway, and Scotland were combined. Patients starting RRT between 1980 and 1999 (n=57371) were included in the analyses. Cox proportional hazards regression was used to predict survival.
Results. The use of different coding systems for ESRD treatment by the registries made it difficult to merge the data. Incidence and prevalence of RRT showed a continuous increase with a marked variation in rates between countries. The 2-, 5- and 10-year patient survival was 67, 35 and 11% in dialysis patients and 90, 81 and 64% after a first renal allograft. Multivariate analysis showed a slightly better survival on dialysis in the 19901994 (RR 0.94, 95% CI 0.900.98) and the 19951999 cohort (RR 0.88, 95% CI 0.840.92) compared to the 19801984 cohort. In contrast, there was a much greater improvement in transplant-patient survival, resulting in a 56% reduction in the risk of death within the 19951999 cohort (RR 0.44, 95% CI 0.390.50) compared to the 19801984 cohort.
Conclusions. This study provides support for the feasibility of a new style ERAEDTA registry and the collection of data is now being extended to other countries. The improvement in patient survival over the last two decades has been much greater in transplant recipients than in dialysis patients.
Keywords: epidemiology; Europe; mortality; primary renal disease; renal replacement therapy; technique survival
Notes
Correspondence and offprint requests to: Kitty J. Jager MD PhD, ERAEDTA Registry, Academic Medical Center, University of Amsterdam, Department of Medical Informatics, J.2254, PO Box 22700, 1100 DE Amsterdam, The Netherlands.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
D. J. de Jager, D. C. Grootendorst, K. J. Jager, P. C. van Dijk, L. M. J. Tomas, D. Ansell, F. Collart, P. Finne, J. G. Heaf, J. De Meester, et al. Cardiovascular and Noncardiovascular Mortality Among Patients Starting Dialysis JAMA, October 28, 2009; 302(16): 1782 - 1789. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hommel, S. Rasmussen, M. Madsen, and A.-L. Kamper The Danish Registry on Regular Dialysis and Transplantation:completeness and validity of incident patient registration Nephrol. Dial. Transplant., October 26, 2009; (2009) gfp571v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Zoccali, A. Kramer, and K. J. Jager Chronic kidney disease and end-stage renal disease--a review produced to contribute to the report 'the status of health in the European union: towards a healthier Europe' NDT Plus, October 12, 2009; (2009) sfp127v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kramer, V. Stel, C. Zoccali, J. Heaf, D. Ansell, C. Gronhagen-Riska, T. Leivestad, K. Simpson, R. Palsson, M. Postorino, et al. An update on renal replacement therapy in Europe: ERA-EDTA Registry data from 1997 to 2006 Nephrol. Dial. Transplant., October 9, 2009; (2009) gfp519v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. L.H. Muntinghe, M. Verduijn, M. W. Zuurman, D. C. Grootendorst, J. J. Carrero, A. R. Qureshi, K. Luttropp, L. Nordfors, B. Lindholm, V. Brandenburg, et al. CCR5 Deletion Protects Against Inflammation-Associated Mortality in Dialysis Patients J. Am. Soc. Nephrol., July 1, 2009; 20(7): 1641 - 1649. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Noordzij, N. M. C. Voormolen, E. W. Boeschoten, F. W. Dekker, W. J. Bos, R. T. Krediet, J. C. Korevaar, and for the NECOSAD study group Disordered mineral metabolism is not a risk factor for loss of residual renal function in dialysis patients Nephrol. Dial. Transplant., May 1, 2009; 24(5): 1580 - 1587. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. M. Michels, M. Verduijn, E. W. Boeschoten, F. W. Dekker, R. T. Krediet, and for the NECOSAD Study Group Similar Survival on Automated Peritoneal Dialysis and Continuous Ambulatory Peritoneal Dialysis in a Large Prospective Cohort Clin. J. Am. Soc. Nephrol., May 1, 2009; 4(5): 943 - 949. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Chen, W. Chen, H. Wang, X. Dong, Q. Liu, H. Mao, J. Tan, J. Lin, F. Zhou, N. Luo, et al. Prevalence and risk factors associated with chronic kidney disease in an adult population from southern China Nephrol. Dial. Transplant., April 1, 2009; 24(4): 1205 - 1212. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Chailimpamontree, S. Dmitrienko, G. Li, R. Balshaw, A. Magil, R. J. Shapiro, D. Landsberg, J. Gill, P. A. Keown, and and the Genome Canada Biomarkers in Transplantatio Probability, Predictors, and Prognosis of Posttransplantation Glomerulonephritis J. Am. Soc. Nephrol., April 1, 2009; 20(4): 843 - 851. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kramer, V. S. Stel, J. Tizard, E. Verrina, K. Ronnholm, R. Palsson, H. Maxwell, and K. J. Jager Characteristics and survival of young adults who started renal replacement therapy during childhood Nephrol. Dial. Transplant., March 1, 2009; 24(3): 926 - 933. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Tazza, A. Di Napoli, M. Bossola, S. Valle, P. Pezzotti, G. Luciani, D. Di Lallo, and on behalf of Lazio Dialysis Registry Ageing of patients on chronic dialysis: Effects on mortality--A 12-year study Nephrol. Dial. Transplant., March 1, 2009; 24(3): 940 - 947. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. de Mutsert, D. C Grootendorst, E. W Boeschoten, H. Brandts, J. G van Manen, R. T Krediet, F. W Dekker, and for the Netherlands Cooperative Study on the Adequ Subjective global assessment of nutritional status is strongly associated with mortality in chronic dialysis patients Am. J. Clinical Nutrition, March 1, 2009; 89(3): 787 - 793. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Kshirsagar, H. Bang, A. S. Bomback, S. Vupputuri, D. A. Shoham, L. M. Kern, P. J. Klemmer, M. Mazumdar, and P. A. August A Simple Algorithm to Predict Incident Kidney Disease Arch Intern Med, December 8, 2008; 168(22): 2466 - 2473. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. de Mutsert, D. C. Grootendorst, J. Axelsson, E. W. Boeschoten, R. T. Krediet, F. W. Dekker, and the NECOSAD Study Group Excess mortality due to interaction between protein-energy wasting, inflammation and cardiovascular disease in chronic dialysis patients Nephrol. Dial. Transplant., September 1, 2008; 23(9): 2957 - 2964. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Liakopoulos, E. Petinaki, G. Efthimiadi, D. Klapsa, M. Giannopoulou, S. Dovas, T. Eleftheriadis, P. R. Mertens, and I. Stefanidis Clonal relatedness of methicillin-resistant coagulase-negative staphylococci in the haemodialysis unit of a single university centre in Greece Nephrol. Dial. Transplant., August 1, 2008; 23(8): 2599 - 2603. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Janus, L.-V. Vacher, S. Karie, E. Ledneva, and G. Deray Vaccination and chronic kidney disease Nephrol. Dial. Transplant., March 1, 2008; 23(3): 800 - 807. [Full Text] [PDF] |
||||
![]() |
R. Calderon-Margalit, E.-S. Gordon, M. Hoshen, J. D. Kark, A. Rotem, and Z. Haklai Dialysis in Israel, 1989-2005--time trends and international comparisons Nephrol. Dial. Transplant., February 1, 2008; 23(2): 659 - 664. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Covic, P. Gusbeth-Tatomir, and D. Goldsmith Negative outcome studies in end-stage renal disease: how dark are the storm clouds? Nephrol. Dial. Transplant., January 1, 2008; 23(1): 56 - 61. [Full Text] [PDF] |
||||
![]() |
N. Voormolen, M. Noordzij, D. C. Grootendorst, I. Beetz, Y. W. Sijpkens, J. G. van Manen, E. W. Boeschoten, R. M. Huisman, R. T. Krediet, F. W. Dekker, et al. High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients Nephrol. Dial. Transplant., October 1, 2007; 22(10): 2909 - 2916. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. de Mutsert, M. B. Snijder, F. van der Sman-de Beer, J. C. Seidell, E. W. Boeschoten, R. T. Krediet, J. M. Dekker, J. P. Vandenbroucke, F. W. Dekker, and for the Netherlands Cooperative Study on the Adequ Association between Body Mass Index and Mortality Is Similar in the Hemodialysis Population and the General Population at High Age and Equal Duration of Follow-Up J. Am. Soc. Nephrol., March 1, 2007; 18(3): 967 - 974. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Krasniak, M. Drozdz, M. Pasowicz, G. Chmiel, M. Michalek, D. Szumilak, P. Podolec, P. Klimeczek, M. Konieczynska, E. Wicher-Muniak, et al. Factors involved in vascular calcification and atherosclerosis in maintenance haemodialysis patients Nephrol. Dial. Transplant., February 1, 2007; 22(2): 515 - 521. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yoshino, M. K. Kuhlmann, P. Kotanko, R. N. Greenwood, R. L. Pisoni, F. K. Port, K. J. Jager, P. Homel, H. Augustijn, F. T. de Charro, et al. International Differences in Dialysis Mortality Reflect Background General Population Atherosclerotic Cardiovascular Mortality J. Am. Soc. Nephrol., December 1, 2006; 17(12): 3510 - 3519. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. I Hallan, K. Dahl, C. M Oien, D. C Grootendorst, A. Aasberg, J. Holmen, and F. W Dekker Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey BMJ, November 18, 2006; 333(7577): 1047 - 1047. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Valdes, M. Garcia-Mendoza, P. Rebollo, T. Ortega, and F. Ortega Mental health at the third month of haemodialysis as a predictor of short-term survival Nephrol. Dial. Transplant., November 1, 2006; 21(11): 3223 - 3230. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M.G.A. El-Ghar, M. Qureshi, A. Shoker, and K. Prasad Oxidative stress in renal transplant patients who develop cardiovascular disease. Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2006; 11(3): 203 - 210. [Abstract] [PDF] |
||||
![]() |
P. A. Sarafidis and G. L. Bakris Microalbuminuria and chronic kidney disease as risk factors for cardiovascular disease Nephrol. Dial. Transplant., September 1, 2006; 21(9): 2366 - 2374. [Full Text] [PDF] |
||||
![]() |
S. I. Hallan, J. Coresh, B. C. Astor, A. Asberg, N. R. Powe, S. Romundstad, H. A. Hallan, S. Lydersen, and J. Holmen International Comparison of the Relationship of Chronic Kidney Disease Prevalence and ESRD Risk J. Am. Soc. Nephrol., August 1, 2006; 17(8): 2275 - 2284. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. P. J. den Elzen, J. G. van Manen, E. W. Boeschoten, R. T. Krediet, and F. W. Dekker The effect of single and repeatedly high concentrations of C-reactive protein on cardiovascular and non-cardiovascular mortality in patients starting with dialysis Nephrol. Dial. Transplant., June 1, 2006; 21(6): 1588 - 1595. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Geddes, P. C. W. van Dijk, S. McArthur, W. Metcalfe, K. J. Jager, A. H. Zwinderman, M. Mooney, J. G. Fox, and K. Simpson The ERA-EDTA cohort study--comparison of methods to predict survival on renal replacement therapy Nephrol. Dial. Transplant., April 1, 2006; 21(4): 945 - 956. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Couchoud, B. Stengel, P. Landais, J.-C. Aldigier, F. de Cornelissen, C. Dabot, H. Maheut, V. Joyeux, M. Kessler, M. Labeeuw, et al. The renal epidemiology and information network (REIN): a new registry for end-stage renal disease in France Nephrol. Dial. Transplant., February 1, 2006; 21(2): 411 - 418. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Meerwaldt, J. W.L. Hartog, R. Graaff, R. J. Huisman, T. P. Links, N. C. den Hollander, S. R. Thorpe, J. W. Baynes, G. Navis, R. O.B. Gans, et al. Skin Autofluorescence, a Measure of Cumulative Metabolic Stress and Advanced Glycation End Products, Predicts Mortality in Hemodialysis Patients J. Am. Soc. Nephrol., December 1, 2005; 16(12): 3687 - 3693. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. V. Rocco, A. K. Cheung, T. Greene, G. Eknoyan, and for the Hemodialysis Study Group The HEMO Study: applicability and generalizability Nephrol. Dial. Transplant., February 1, 2005; 20(2): 278 - 284. [Full Text] [PDF] |
||||
![]() |
T.G. Feest, J. Rajamahesh, C. Byrne, A. Ahmad, D. Ansell, R. Burden, and P.J. Roderick Trends in adult renal replacement therapy in the UK: 1982-2002 QJM, January 1, 2005; 98(1): 21 - 28. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Paoletti, C. Specchia, G. Di Maio, D. Bellino, B. Damasio, P. Cassottana, and G. Cannella The worsening of left ventricular hypertrophy is the strongest predictor of sudden cardiac death in haemodialysis patients: a 10 year survey Nephrol. Dial. Transplant., July 1, 2004; 19(7): 1829 - 1834. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Termorshuizen, F. W. Dekker, J. G. van Manen, J. C. Korevaar, E. W. Boeschoten, and R. T. Krediet Relative Contribution of Residual Renal Function and Different Measures of Adequacy to Survival in Hemodialysis Patients: An analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2 J. Am. Soc. Nephrol., April 1, 2004; 15(4): 1061 - 1070. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Termorshuizen, J. C. Korevaar, F. W. Dekker, J. G. van Manen, E. W. Boeschoten, and R. T. Krediet Hemodialysis and Peritoneal Dialysis: Comparison of Adjusted Mortality Rates According to the Duration of Dialysis: Analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis 2 J. Am. Soc. Nephrol., November 1, 2003; 14(11): 2851 - 2860. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Stengel, S. Billon, P. C.W. van Dijk, K. J. Jager, F. W. Dekker, K. Simpson, and J. D. Briggs Trends in the incidence of renal replacement therapy for end-stage renal disease in Europe, 1990-1999 Nephrol. Dial. Transplant., September 1, 2003; 18(9): 1824 - 1833. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Wimmer, W. Oberaigner, R. Kramar, and G. Mayer Regional variability in the incidence of end-stage renal disease: an epidemiological approach Nephrol. Dial. Transplant., August 1, 2003; 18(8): 1562 - 1567. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Wimmer, W. Oberaigner, R. Kramar, and G. Mayer Regional variability in the incidence of end-stage renal disease: an epidemiological approach Nephrol. Dial. Transplant., August 1, 2003; 18(88): 1562 - 1567. [Abstract] [Full Text] |
||||
![]() |
S. J. Chadban, E. M. Briganti, P. G. Kerr, D. W. Dunstan, T. A. Welborn, P. Z. Zimmet, and R. C. Atkins Prevalence of Kidney Damage in Australian Adults: The AusDiab Kidney Study J. Am. Soc. Nephrol., July 1, 2003; 14(90002): S131 - 138. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Korevaar, F. W. Dekker, and R. T. Krediet Initiation of dialysis: is the problem solved by NECOSAD? Nephrol. Dial. Transplant., June 1, 2003; 18(6): 1228 - 1229. [Full Text] [PDF] |
||||
![]() |
E. Mesic, H. Resic, A. Halilbasic, I. Komljenovic, M. Vasilj, L. Vucicevic, and S. Trnacevic Renal replacement therapy in Bosnia and Herzegovina: report of the Society of Nephrology, Dialysis and Transplantation of Bosnia and Herzegovina Nephrol. Dial. Transplant., April 1, 2003; 18(4): 661 - 663. [Full Text] [PDF] |
||||
![]() |
M. L. Caramori, P. Fioretto, and M. Mauer Low Glomerular Filtration Rate in Normoalbuminuric Type 1 Diabetic Patients: An Indicator of More Advanced Glomerular Lesions Diabetes, April 1, 2003; 52(4): 1036 - 1040. [Abstract] [Full Text] [PDF] |
||||










